---
url: https://www.servicesaustralia.gov.au/ankylosing-spondylitis
title: Ankylosing spondylitis - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:39:58.176Z
source: servicesaustralia.gov.au
---
# Ankylosing spondylitis

The PBS subsidises biological medicines for patients with ankylosing spondylitis.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with biological medicines under the _National Health Act 1953_, section 85 and section 100 for adult patients with ankylosing spondylitis.

Where the term biological medicine appears it refers to:

-   adalimumab
-   bimekizumab
-   certolizumab pegol
-   etanercept
-   golimumab
-   infliximab
-   ixekizumab
-   secukinumab
-   tofacitinib
-   upadacitinib.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home;jsessionid=10uww6tlz5cky2sw3t03f7ac5) on the PBS website outlines the restrictions for prescribing biological medicines.

## Section 100 arrangements

### Infliximab IV

This item is only PBS-subsidised for non-admitted patients, day admitted patients or patients on discharge who are attending either:

-   an approved private hospital
-   a public hospital.

This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Treatment specifics

To be eligible for PBS-subsidised treatment with biological medicines, patients must be treated by either a:

-   rheumatologist
-   clinical immunologist with expertise in managing ankylosing spondylitis.

## Authority applications

### Biosimilars

#### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised biosimilar brands of biological medicines to treat ankylosing spondylitis can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

#### Applying for change or recommencement of treatment

Applications to change or recommence authority approval to prescribe PBS-subsidised biosimilar brands of biological medicines to treat ankylosing spondylitis can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

#### Applying for continuing treatment

Application for continuing PBS-subsidised treatment with biosimilar brands of biological medicines is Authority required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

### Originators

#### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial authority approval to prescribe PBS-subsidised biological medicines to treat ankylosing spondylitis can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ankylosing spondylitis - initial authority application form](/pb073?context=20)
-   relevant attachments.

#### Applying for change or recommencement of treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications to change or recommence authority approval to prescribe PBS-subsidised biological medicines to treat ankylosing spondylitis can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ankylosing spondylitis - change or recommencement authority application form](/pb251?context=20)
-   relevant attachments.

#### Applying for continuing treatment - excluding infliximab SC

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

Applications for continuing authority approval to prescribe PBS-subsidised biological medicines to treat ankylosing spondylitis can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ankylosing spondylitis - continuing authority application form](/pb074?context=20)
-   relevant attachments.

After we approve the first application for continuing treatment, subsequent continuing treatments with PBS-subsidised biosimilar brands of biological medicines are Authority Required (Streamlined). You don’t need authority approval from us for the listed quantity and repeats.

#### Applying for continuing treatment - infliximab SC

Continuing PBS-subsidised treatment with infliximab SC is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.

[

Ankylosing spondylitis toxicity and severity descriptors

Toxicity and severity descriptors for Nonsteroidal Anti-inflammatory Drug (NSAID) therapy required to be trialled before accessing PBS-subsidised biological medicines to treat ankylosing spondylitis.


](/ankylosing-spondylitis-toxicity-and-severity-descriptors?context=20)
